[Table/Fig-3]:

Association of early and advanced stages of cervical cancer with miRNA gene polymorphism.

miRNA gene polymorphisms	Early stages (I + II) n (%)	Advanced stages (III +IV) n (%)	p-value	OR* (95%CI)
miRNA 146a
GG	37 (44.04)	44 (44%)	-	Reference
GC	38 (45.23)	47 (47%)	0.338	0.739 (0.398-1.373)
CC	9 (10.71)	9 (9%)	0.044	0.329 (0.11- 0.970)
miRNA 196a2
CC	11 (13.09%)	9 (9%)	-	Reference
CT	46 (54.76%)	47 (47%)	0.141	0.623 (0.332-1.169)
TT	27 (32.14%)	44 (44%)	0.153	0.475 (0.171- 1.319)
miRNA 499
TT	10 (11.9%)	16 (16%)	-	Reference
CT	37 (44.04%)	41 (41%)	0.244	0.577 (0.229 -1.454)
CC	37 (44.04%)	43 (43%)	0.290	(0.241-1.529)

*OR = odds ratio